Mechanism of Banxia Xiexintang in Prevention and Treatment of Gastric Cancer： A Review
10.13422/j.cnki.syfjx.20230830
- VernacularTitle:半夏泻心汤防治GC作用机制研究进展
- Author:
Yanmei ZHANG
1
;
Jingjing WEI
1
;
Zhongbo ZHU
1
;
Senyu LIU
2
;
Fan YANG
1
;
Xiping LIU
1
;
Peiqing LI
1
Author Information
1. Gansu Engineering Laboratory for New Products of Traditional Chinese Medicine（TCM），Gansu Key Laboratory of TCM Excavation and Innovative Transformation，Gansu University of Chinese Medicine，Lanzhou 730000， China
2. The First Clinical Collage， Hainan Medical University， Haikou 571199，China
- Publication Type:Journal Article
- Keywords:
Banxia Xiexintang;
gastric cancer;
material basis;
mechanism;
research progress
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2023;29(10):65-72
- CountryChina
- Language:Chinese
-
Abstract:
Gastric cancer （GC） is one of the common malignant tumors， and the incidence and mortality of GC in China rank first in the world. At present， the pathogenesis of GC has not been fully clarified. Although surgery， radiotherapy， chemotherapy， targeted therapy， and immunotherapy have achieved good results in the treatment of GC， there are still many complications， decreased sensitivity， and severe side effects. Banxia Xiexintang， derived from Treatise on Cold Damage and Miscellaneous Diseases（《伤寒杂病论》）， has been clinically used for more than 2000 years with the effects of combining cold and warm drugs， dissipating mass， and relieving stuffiness， and is a classic prescription for treating digestive tract diseases in later generations. Through clinical observation and experimental research， it is found that Banxia Xiexintang and its single drugs have good effect in preventing and treating GC. Chinese medicine has multi-component and multi-target characteristics and can treat GC through various mechanisms. Therefore， it is necessary to carry out systematic and in-depth research from the aspects of molecular biology and network pharmacology， and comprehensively reveal the mechanism of Banxia Xiexintang in preventing and treating GC. At present， the mechanism of Banxia Xiexintang in treating GC mainly focuses on inducing apoptosis of GC cells， inhibiting proliferation， migration， and invasion of GC cells， protecting peritoneal mesothelial cells， inhibiting peritoneal metastasis of GC cells， regulating GC microenvironment， and inhibiting the malignant transformation of bone marrow mesenchymal stem cells （BMSCs）. This research group is committed to the prevention and treatment of GC with Banxia Xiexintang， aiming to comprehensively reveal the mechanism of action and the pharmacodynamic material basis of Banxia Xiexintang in the prevention and treatment of GC， and provide an important scientific basis for further clinical application of Banxia Xiexintang. After searching CNKI， PubMed， Wanfang Data， VIP， and other databases， this paper summarized Banxia Xiexintang in the treatment of GC from the aspects of prescription basis， material basis， network pharmacology， clinical and experimental studies， etc.， so as to provide references for further research on pharmacological effect of Banxia Xiexintang and its application in the clinical treatment of GC.
